Additionally, the 36-month beta value for AGL is 0.54. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 2 rating it as “overweight,” 13 rating it as “hold,” and 1 rating it as “sell.”
The public float for AGL is 302.82M and currently, short sellers hold a 13.02% ratio of that float. The average trading volume of AGL on September 30, 2024 was 4.77M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
AGL) stock’s latest price update
Agilon Health Inc (NYSE: AGL)’s stock price has soared by 2.01 in relation to previous closing price of 3.74. Nevertheless, the company has seen a loss of -0.65% in its stock price over the last five trading days. seekingalpha.com reported 2024-08-16 that agilon hagilon healthealth shares dropped significantly after disappointing financial results, down 11.9% in two days. The company’s revenue surged 38.7% year over year, but its net loss nearly doubled, and guidance for 2024 is mixed. Concerns include declining cash reserves, potential for further dilution, and uncertainty regarding share valuation.
AGL’s Market Performance
Agilon Health Inc (AGL) has experienced a -0.65% fall in stock performance for the past week, with a -8.29% drop in the past month, and a -37.15% drop in the past quarter. The volatility ratio for the week is 7.42%, and the volatility levels for the past 30 days are at 9.18% for AGL. The simple moving average for the past 20 days is 3.36% for AGL’s stock, with a -39.28% simple moving average for the past 200 days.
Analysts’ Opinion of AGL
Many brokerage firms have already submitted their reports for AGL stocks, with Robert W. Baird repeating the rating for AGL by listing it as a “Neutral.” The predicted price for AGL in the upcoming period, according to Robert W. Baird is $6 based on the research report published on May 30, 2024 of the current year 2024.
Citigroup, on the other hand, stated in their research note that they expect to see AGL reach a price target of $6. The rating they have provided for AGL stocks is “Neutral” according to the report published on April 22nd, 2024.
Barclays gave a rating of “Underweight” to AGL, setting the target price at $5 in the report published on March 06th of the current year.
AGL Trading at -21.98% from the 50-Day Moving Average
After a stumble in the market that brought AGL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -81.27% of loss for the given period.
Volatility was left at 9.18%, however, over the last 30 days, the volatility rate increased by 7.42%, as shares sank -6.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -44.63% lower at present.
During the last 5 trading sessions, AGL fell by -0.65%, which changed the moving average for the period of 200-days by -69.03% in comparison to the 20-day moving average, which settled at $3.68. In addition, Agilon Health Inc saw -69.60% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AGL starting from Sell Steven, who purchase 20,000 shares at the price of $3.36 back on Sep 12 ’24. After this action, Sell Steven now owns 67,590 shares of Agilon Health Inc, valued at $67,188 using the latest closing price.
Schwaneke Jeffrey A., the Director of Agilon Health Inc, purchase 22,300 shares at $11.22 during a trade that took place back on Nov 29 ’23, which means that Schwaneke Jeffrey A. is holding 31,931 shares at $250,206 based on the most recent closing price.
Stock Fundamentals for AGL
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.0 for the gross margin
The net margin for Agilon Health Inc stands at -0.05. The total capital return value is set at -0.34. Equity return is now at value -29.03, with -10.01 for asset returns.
Based on Agilon Health Inc (AGL), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -3.9. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is -39.32.
Currently, EBITDA for the company is -211.78 million with net debt to EBITDA at 0.32. When we switch over and look at the enterprise to sales, we see a ratio of 0.28. The receivables turnover for the company is 3.73for trailing twelve months and the total asset turnover is 2.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.36.
Conclusion
In conclusion, Agilon Health Inc (AGL) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
